What is Amigo?
Amigo AI is a healthcare technology company specializing in the development and training of patient-facing clinical AI agents. These advanced agents are engineered to facilitate direct patient interactions across a spectrum of healthcare workflows, including patient intake, triage, personalized care navigation, and ongoing patient support. By enabling healthcare organizations to improve communication and streamline care delivery, Amigo's solutions are instrumental in shaping AI strategies and deploying customized, secure agents within diverse clinical environments.
How much funding has Amigo raised?
Amigo has raised a total of $11M across 1 funding round:
Series A
$11M
Series A (2026): $11M with participation from Madrona Venture Group and Optum Ventures
Key Investors in Amigo
Madrona Venture Group
Madrona Venture Group, established in 1995, is a venture capital firm known for its investments in consumer internet, commercial software, and services, indicating a strategic interest in technology-forward companies.
Optum Ventures
Optum Ventures is dedicated to improving healthcare through investments in early-stage companies that challenge the status quo, aligning with Amigo's mission to transform patient interaction via AI.
What's next for Amigo?
With the recent major strategic investment, Amigo is poised for accelerated growth and innovation. The company is expected to leverage this capital to expand its market reach, further refine its AI agent technology, and enhance its integration capabilities within existing healthcare systems. This funding round, part of a larger $11M in enterprise-level financing, suggests Amigo is entering a scaling phase, aiming to solidify its position as a leader in AI-powered patient engagement and clinical support solutions. Future developments will likely focus on broadening the application of its AI agents across more complex healthcare scenarios and deepening partnerships with healthcare providers.
See full Amigo company page
